Edgewise Therapeutics Inc (EWTX)
32.50
+0.52
(+1.63%)
USD |
NASDAQ |
Nov 22, 13:27
Edgewise Therapeutics Total Liabilities (Quarterly): 22.40M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.40M |
| June 30, 2024 | 21.17M |
| March 31, 2024 | 18.86M |
| December 31, 2023 | 21.20M |
| September 30, 2023 | 20.94M |
| June 30, 2023 | 19.17M |
| March 31, 2023 | 17.56M |
| December 31, 2022 | 20.38M |
| Date | Value |
|---|---|
| September 30, 2022 | 15.75M |
| June 30, 2022 | 11.04M |
| March 31, 2022 | 12.39M |
| December 31, 2021 | 10.85M |
| September 30, 2021 | 9.049M |
| June 30, 2021 | 6.739M |
| March 31, 2021 | 4.851M |
| December 31, 2020 | 164.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.851M
Minimum
Mar 2021
164.56M
Maximum
Dec 2020
24.81M
Average
18.21M
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 111.07M |
| Cytokinetics Inc | 1.450B |
| Vanda Pharmaceuticals Inc | 103.89M |
| Vertex Pharmaceuticals Inc | 6.609B |
| Sarepta Therapeutics Inc | 2.379B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 511.28M |
| Shareholders Equity (Quarterly) | 488.88M |